Abstract
Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare disorder caused by mutations in the
Immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare disorder caused by mutations in the
B. R. Powell, N. R. M. Buist, and P. Stenzel, “An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy,” The Journal of Pediatrics, vol. 100, no. 5, pp. 731–737, 1982.
View at: Publisher Site | Google ScholarT. R. Torgerson, “Regulatory T cells in human autoimmune diseases,” Springer Seminars in Immunopathology, vol. 28, no. 1, pp. 63–76, 2006.
View at: Publisher Site | Google ScholarR. S. Wildin, S. Smyk-Pearson, and A. H. Filipovich, “Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome,” Journal of Medical Genetics, vol. 39, no. 8, pp. 537–545, 2002.
View at: Publisher Site | Google ScholarR. S. Wildin, F. Ramsdell, J. Peake et al., “X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy,” Nature Genetics, vol. 27, no. 1, pp. 18–20, 2001.
View at: Publisher Site | Google ScholarC. L. Bennett, J. Christie, F. Ramsdell et al., “The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of ,” Nature Genetics, vol. 27, no. 1, pp. 20–21, 2001.
View at: Publisher Site | Google ScholarM. E. Brunkow, E. W. Jeffery, K. A. Hjerrild et al., “Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse,” Nature Genetics, vol. 27, no. 1, pp. 68–73, 2001.
View at: Publisher Site | Google ScholarC. J. Owen, C. E. Jennings, H. Imrie et al., “Mutational analysis of the gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 12, pp. 6034–6039, 2003.
View at: Publisher Site | Google ScholarC. L. Bennett, M. E. Brunkow, F. Ramsdell et al., “A rare polyadenylation signal mutation of the gene leads to the IPEX syndrome,” Immunogenetics, vol. 53, no. 6, pp. 435–439, 2001.
View at: Publisher Site | Google ScholarA. K. Myers, L. Perroni, C. Costigan, and W. Reardon, “Clinical and molecular findings in IPEX syndrome,” Archives of Disease in Childhood, vol. 91, no. 1, pp. 63–64, 2006.
View at: Publisher Site | Google ScholarS. Le Bras and R. S. Geha, “IPEX and the role of in the development and function of human Tregs,” Journal of Clinical Investigation, vol. 116, no. 6, pp. 1473–1475, 2006.
View at: Publisher Site | Google ScholarS. F. Ziegler, “: of mice and men,” Annual Review of Immunology, vol. 24, pp. 209–226, 2006.
View at: Publisher Site | Google ScholarJ. E. Lopes, T. R. Torgerson, L. A. Schubert et al., “Analysis of reveals multiple domains required for its function as a transcriptional repressor,” The Journal of Immunology, vol. 177, no. 5, pp. 3133–3142, 2006.
View at: Google ScholarD. J. Campbell and S. F. Ziegler, “ modifies the phenotypic and functional properties of regulatory T cells,” Nature Reviews Immunology, vol. 7, no. 4, pp. 305–310, 2007.
View at: Publisher Site | Google ScholarM. Kronenberg and A. Rudensky, “Regulation of immunity by self-reactive T cells,” Nature, vol. 435, no. 7042, pp. 598–604, 2005.
View at: Publisher Site | Google ScholarL. A. Schubert, E. Jeffery, Y. Zhang, F. Ramsdell, and S. F. Ziegler, “Scurfin () acts as a repressor of transcription and regulates T cell activation,” Journal of Biological Chemistry, vol. 276, no. 40, pp. 37672–37679, 2001.
View at: Publisher Site | Google ScholarY. Wu, M. Borde, V. Heissmeyer et al., “ controls regulatory T cell function through cooperation with NFAT,” Cell, vol. 126, no. 2, pp. 375–387, 2006.
View at: Publisher Site | Google ScholarS. Sakaguchi, “Naturally arising -expressing regulatory T cells in immunological tolerance to self and non-self,” Nature Immunology, vol. 6, no. 4, pp. 345–352, 2005.
View at: Publisher Site | Google ScholarO. Baud, O. Goulet, D. Canioni et al., “Treatment of the immune dysregulation, polyendoccrinopathy, enteropathy, X-linked syndrome (IPEX) by allogeneic bone marrow transplantation,” The New England Journal of Medicine, vol. 344, no. 23, pp. 1758–1762, 2001.
View at: Publisher Site | Google ScholarM. L. Heltzer, J. K. Choi, H. D. Ochs, K. E. Sullivan, T. R. Torgerson, and L. M. Ernst, “A potential screening tool for IPEX syndrome,” Pediatric and Developmental Pathology, vol. 10, no. 2, pp. 98–105, 2007.
View at: Publisher Site | Google ScholarL. Bindl, T. Torgerson, L. Perroni et al., “Successful use of the new immune-suppressor sirolimus in IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome),” The Journal of Pediatrics, vol. 147, no. 2, pp. 256–259, 2005.
View at: Publisher Site | Google ScholarP. J. Ferguson, S. H. Blanton, F. T. Saulsbury et al., “Manifestations and linkage analysis in X-linked autoimmunity-immunodeficiency syndrome,” American Journal of Medical Genetics, vol. 90, no. 5, pp. 390–397, 2000.
View at: Publisher Site | Google ScholarN. Satake, M. Nakanishi, M. Okano et al., “A Japanese family of X-linked auto-immune enteropathy with haemolytic anaemia and polyendocrinopathy,” European Journal of Pediatrics, vol. 152, no. 4, pp. 313–315, 1993.
View at: Publisher Site | Google ScholarI. Kobayashi, M. Nakanishi, M. Okano, Y. Sakiyama, and S. Matsumoto, “Combination therapy with tacrolimus and betamethasone for a patient with X-linked auto-immune enteropathy,” European Journal of Pediatrics, vol. 154, no. 7, pp. 594–595, 1995.
View at: Publisher Site | Google ScholarI. Kobayashi, N. Kawamura, and M. Okano, “A long-term survivor with the immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome,” The New England Journal of Medicine, vol. 345, no. 13, pp. 999–1000, 2001.
View at: Publisher Site | Google ScholarR. Bacchetta, L. Passerini, E. Gambineri et al., “Defective regulatory and effector T cell functions in patients with mutations,” Journal of Clinical Investigation, vol. 116, no. 6, pp. 1713–1722, 2006.
View at: Publisher Site | Google ScholarA. Rao, N. Kamani, A. Filipovich et al., “Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning,” Blood, vol. 109, no. 1, pp. 383–385, 2007.
View at: Publisher Site | Google ScholarT. J. Curiel, G. Coukos, L. Zou et al., “Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival,” Nature Medicine, vol. 10, no. 9, pp. 942–949, 2004.
View at: Publisher Site | Google ScholarJ. Dannull, Z. Su, D. Rizzieri et al., “Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells,” Journal of Clinical Investigation, vol. 115, no. 12, pp. 3623–3633, 2005.
View at: Publisher Site | Google Scholar